skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: ClinicalKey remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

Denkert, Carsten, Dr ; Liedtke, Cornelia, MD ; Tutt, Andrew, MD ; von Minckwitz, Gunter, MD

The Lancet (British edition), 2017-06, Vol.389 (10087), p.2430-2442 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Tumor infiltrating lymphocytes in early breast cancer
Tumor infiltrating lymphocytes in early breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumor infiltrating lymphocytes in early breast cancer

Pruneri, Giancarlo, MD ; Vingiani, Andrea, MD ; Denkert, Carsten, MD

Breast (Edinburgh), 2018-02, Vol.37, p.207-214 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

Dieci, Maria Vittoria ; Radosevic-Robin, Nina ; Fineberg, Susan ; van den Eynden, Gert ; Ternes, Nils ; Penault-Llorca, Frederique ; Pruneri, Giancarlo ; D’Alfonso, Timothy M. ; Demaria, Sandra ; Castaneda, Carlos ; Sanchez, Joselyn ; Badve, Sunil ; Michiels, Stefan ; Bossuyt, Veerle ; Rojo, Federico ; Singh, Baljit ; Nielsen, Torsten ; Viale, Giuseppe ; Kim, Seong-Rim ; Hewitt, Stephen ; Wienert, Stephan ; Loibl, Sybille ; Rimm, David ; Symmans, Fraser ; Denkert, Carsten ; Adams, Sylvia ; Loi, Sherene ; Salgado, Roberto

Seminars in cancer biology, 2018-10, Vol.52 (Pt 2), p.16-25 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

von Minckwitz, Gunter, Prof ; Schneeweiss, Andreas, Prof ; Loibl, Sibylle, Prof ; Salat, Christoph, MD ; Denkert, Carsten, Prof ; Rezai, Mahdi, Prof ; Blohmer, Jens U, Prof ; Jackisch, Christian, Prof ; Paepke, Stefan, MD ; Gerber, Bernd, Prof ; Zahm, Dirk M, MD ; Kümmel, Sherko, MD ; Eidtmann, Holger, MD ; Klare, Peter, MD ; Huober, Jens, Prof ; Costa, Serban, Prof ; Tesch, Hans, Prof ; Hanusch, Claus, MD ; Hilfrich, Jörn, Prof ; Khandan, Fariba, MD ; Fasching, Peter A, Prof ; Sinn, Bruno V, MD ; Engels, Knut, MD ; Mehta, Keyur, MBA ; Nekljudova, Valentina, PhD ; Untch, Michael, Prof

The lancet oncology, 2014-06, Vol.15 (7), p.747-756 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial

Untch, Michael, Prof ; Jackisch, Christian, Prof ; Schneeweiss, Andreas, Prof ; Conrad, Bettina, MD ; Aktas, Bahriye, MD ; Denkert, Carsten, Prof ; Eidtmann, Holger, MD ; Wiebringhaus, Hermann, MD ; Kümmel, Sherko, MD ; Hilfrich, Jörn, Prof ; Warm, Mathias, Prof ; Paepke, Stefan, MD ; Just, Marianne, MD ; Hanusch, Claus, MD ; Hackmann, John, MD ; Blohmer, Jens-Uwe, Prof ; Clemens, Michael, Prof ; Darb-Esfahani, Silvia, MD ; Schmitt, Wolfgang Daniel, MD ; Dan Costa, Serban, Prof ; Gerber, Bernd, Prof ; Engels, Knut, MD ; Nekljudova, Valentina, PhD ; Loibl, Sibylle, Prof ; von Minckwitz, Gunter, Prof

The lancet oncology, 2016-03, Vol.17 (3), p.345-356 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis

Weichert, Wilko, Dr ; Röske, Annika ; Gekeler, Volker, PhD ; Beckers, Thomas, PhD ; Ebert, Matthias PA, Prof ; Pross, Matthias, MD ; Dietel, Manfred, Prof ; Denkert, Carsten, MD ; Röcken, Christoph, Prof

The lancet oncology, 2008-02, Vol.9 (2), p.139-148 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials
Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials

Werutsky, Gustavo ; Untch, Michael ; Hanusch, Claus ; Fasching, Peter A. ; Blohmer, Jens-Uwe ; Seiler, Sabine ; Denkert, Carsten ; Tesch, Hans ; Jackisch, Christian ; Gerber, Bernd ; Schneeweiss, Andreas ; Link, Theresa ; Krug, David ; Huober, Jens ; Rhiem, Kerstin ; Kühn, Thorsten ; Vladimirova, Valentina ; Nekljudova, Valentina ; Loibl, Sibylle

European journal of cancer (1990), 2020-05, Vol.130, p.92-101 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes

Tray, Nancy ; Taff, Jessica ; Singh, Baljit ; Suh, James ; Ngo, Nhu ; Kwa, Maryann ; Troxel, Andrea B. ; Chae, Young Kwang ; Kurzrock, Razelle ; Patel, Sandip Pravin ; Sharon, Elad ; Denkert, Carsten ; Ross, Jeffrey S. ; Adams, Sylvia

Breast (Edinburgh), 2019-04, Vol.44, p.29-32 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network
Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network

Sehouli, Jalid ; Braicu, Elena Ioana ; Richter, Rolf ; Denkert, Carsten ; Jank, Paul ; Jurmeister, Philipp Sebastian ; Kunze, Catarina Alisa ; Budczies, Jan ; Darb-Esfahani, Sylvia ; Schmitt, Wolfgang Daniel ; Traut, Alexander ; Grabowski, Jacek ; Taube, Eliane Tabea ; Plett, Helmut

Human pathology, 2019-03, Vol.85, p.299-308 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer

Hoffmann, Inga ; Dragomir, Mihnea P. ; Monjé, Nanna ; Keunecke, Carlotta ; Kunze, Catarina Alisa ; Schallenberg, Simon ; Marchenko, Sofya ; Schmitt, Wolfgang D. ; Kulbe, Hagen ; Sehouli, Jalid ; Braicu, Ioana Elena ; Jank, Paul ; Denkert, Carsten ; Darb-Esfahani, Silvia ; Horst, David ; Sinn, Bruno V. ; Sers, Christine ; Bischoff, Philip ; Taube, Eliane T.

Neoplasia (New York, N.Y.), 2023-10, Vol.44, p.100934-100934, Article 100934 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2005  (7)
  2. 2005Até2009  (9)
  3. 2010Até2013  (9)
  4. 2014Até2018  (21)
  5. Após 2018  (33)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.